Haoxi Health closes $4M direct offering via Univest Securities

Haoxi Health Technology Ltd (NASDAQ: HAO), a Beijing-based online marketing services provider focused on China's healthcare sector, has closed a $4 million registered direct offering, with Univest Securities, LLC acting as sole placement agent, according to a press release.

Under the terms of the securities purchase agreement, the company sold 10,000,000 Class A ordinary shares, or pre-funded warrants in lieu thereof, at an offering price of $0.40 per share. The exercise price for the pre-funded warrants is $0.33 per share, with the purchase price equal to the share offering price less that exercise price amount.

The offering was made pursuant to a shelf registration statement on Form F-3 (File No. 333-287686), which the U.S. Securities and Exchange Commission declared effective on June 13, 2025.

Haoxi Health Technology provides online marketing solutions, including short video marketing, to healthcare advertisers on platforms such as Toutiao, Douyin, WeChat, and Sina Weibo.

You May Also Be Interested In

• EShallGo closes $1.75M registered direct offering at $1 per share
• Singularity Future Technology closes $1.8M registered direct offering
• Winnebago Industries extends $350M credit facility to 2031